Personalized Remote Patient Management in Heart Failure
Open Access
- 19 October 2026
- journal article
- review article
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 23 (1) , 49
Abstract
Purpose of Review: Implanted pulmonary artery pressure (PAP) monitoring provides an early window on imminent worsening heart failure (HF). Randomized trials demonstrated that PAP-guided management significantly reduces HF hospitalizations, but substantial residual risk persists despite recent major advances in HF pharmacotherapy. We review lessons from PAP-guided remote patient management and examine how artificial intelligence (AI) could support more individualized eligibility assessment and multimodal longitudinal surveillance within a patient-centered adaptive care cycle to further improve clinical outcomes. Recent Findings: HF is increasingly recognized as a systemic disease characterized, across HF phenotypes, by multiple cardiac and non-cardiac comorbidities. CHAMPION, GUIDE-HF, and MONITOR-HF did not systematically incorporate comorbidity-related risk into patient selection, while PAP-guided treatment focused predominantly on diuretic adjustment, and monitoring strategies were not adapted to individual disease trajectories. Summary: AI could help integrate multidimensional phenotyping to estimate individual risk and expected benefit pre-implant, use comprehensive longitudinal monitoring data to support personalized, actionable clinical decision-making, and enable dynamic adaptation of monitoring intensity tailored to the disease trajectory. This may improve clinical outcomes, reduce healthcare professional workload, enhance patient experience and treatment adherence, and increase cost-effectiveness.Keywords
This publication has 18 references indexed in Scilit:
- Remote Pulmonary Artery Pressure-Guided Management of Patients with Heart Failure: A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESCEuropean Journal of Heart Failure, 2025
- Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection FractionJACC, 2024
- Digital Technologies to Support Better Outcome and Experience of Care in Patients with Heart FailureCurrent Heart Failure Reports, 2022
- The Digital Future of Heart Failure CareCurrent Heart Failure Reports, 2022
- Pulmonary artery sensor system pressure monitoring to improve heart failure outcomes (PASSPORT-HF): rationale and design of the PASSPORT-HF multicenter randomized clinical trialClinical Research in Cardiology, 2022
- Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection FractionJACC, 2017
- Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure MonitoringJACC: Heart Failure, 2016
- Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trialThe Lancet, 2016
- Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trialThe Lancet, 2014
- Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trialThe Lancet, 2011